世界の細胞株開発市場2020-2027:製品別(機器、培地、試薬)、種類別、用途別、地域別

◆英語タイトル:Global Cell Line Development Market Size study, by Product (Equipment, Media, Reagents), Type (Primary Cell Lines, Continuous Cell Lines, Hybridomas, Recombinant Cell Lines) by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) and Regional Forecasts 2020-2027
◆商品コード:BZW20OC123
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年10月20日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、日本、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥534,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥675,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査資料では、細胞株開発の世界市場を広く調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、市場分析、製品別(機器、培地、試薬)分析、種類別(一次細胞株、連続細胞株、ハイブリドーマ、組換え細胞株)分析、用途別(バイオプロダクション、組織エンジニアリング・再生医療、毒性試験、研究、創薬)分析、地域別分析、競争状況、調査プロセスなど、以下の構成でまとめております。

・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・市場分析
・細胞株開発の世界市場規模:製品別(機器、培地、試薬)
・細胞株開発の世界市場規模:種類別(一次細胞株、連続細胞株、ハイブリドーマ、組換え細胞株)
・細胞株開発の世界市場規模:用途別(バイオプロダクション、組織エンジニアリング・再生医療、毒性試験、研究、創薬)
・細胞株開発の世界市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Cell Line Development Market is valued approximately USD 4.21 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 13.40 % over the forecast period 2020-2027. The cell line is an established cell culture where the cell multiply in apt growth medium and space. The cell lines provide stepwise alternations in the physiology, structure and genetic makeup of the cells. Cell line development requires the discovery of single cell-derived clones that produce high and consistent levels of the target therapeutic protein. Cell lines are one of the chief tools used in research for studying the effects of drugs and toxic compounds on the cells , the biochemistry and normal physiology of cells, drug screening and development and large scale manufacturing of biological compounds.

The application for cell lines includes research, bioproduction and diagnostics drives the market growth. Also, increasing demand for monoclonal antibodies and patent expiration of blockbuster biologics are expected to drive the cell line development industry over the forecast period. Further, increasing prevalence of autoimmune diseases and cancer is likely to increase the demand for accurate and cost-effective treatment options which is expected to render a positive impact on market growth. Moreover, rising vaccine production and growing demand for biosimilars foster the market growth. As in September 2020, Slentim launched a new workflow for single cell cloning of stem cells. the combination of Solentium’s VIPS instrument and new MatriClone Matrix demonstrates a 4 to 5- fold improvement in cloingcloning efficiency. While in the Same month, Octapharma announced to have selected Genedata’s Selector as its Central computational platform to streamline genomics- based cell line development and cell culture optimization workflow. However, High capital cost impedes the growth of the market over the forecast period of 2020-2027. Although, high investments in R&D presents a lucrative opportunity for the market.

The regional analysis of global Cell Line Development market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the large base of biopharmaceutical companies and research and academic institutes in the region along with swelling research programs. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rapidly improving health care facilities would create lucrative growth prospects for the Cell Line Development market across Asia-Pacific region.

Major market player included in this report are:
American Type Culture Collection (ATCC)
Lonza Group AG
Thermo Fisher Scientific Inc
GE Healthcare
Sigma-Aldrich Corporation
Selexis SA
European Collection of Cell Cultures (ECACC)
Corning, Inc
WuXi AppTec, Inc
Sartorious AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Equipment
Media
Reagents

By Type:
Primary Cell Lines
Continuous Cell Lines
Hybridomas
Recombinant Cell Lines

By Application:
Bioproduction
Tissue Engineering & Regenerative medicine
Toxicity Testing
Research
Drug Discovery

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Cell Line Development Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Cell Line Development Market, by Region, 2018-2027 (USD Billion)
1.2.2. Cell Line Development Market, by Product, 2018-2027 (USD Billion)
1.2.3. Cell Line Development Market, by Type, 2018-2027 (USD Billion)
1.2.4. Cell Line Development Market, by Application, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cell Line Development Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cell Line Development Market Dynamics
3.1. Cell Line Development Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Cell Line Development Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cell Line Development Market, by Product
5.1. Market Snapshot
5.2. Global Cell Line Development Market by Product, Performance – Potential Analysis
5.3. Global Cell Line Development Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4. Cell Line Development Market, Sub Segment Analysis
5.4.1. Equipment
5.4.2. Media
5.4.3. Reagents
Chapter 6. Global Cell Line Development Market, by Type
6.1. Market Snapshot
6.2. Global Cell Line Development Market by Type, Performance – Potential Analysis
6.3. Global Cell Line Development Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
6.4. Cell Line Development Market, Sub Segment Analysis
6.4.1. Primary Cell Lines
6.4.2. Continuous Cell Lines
6.4.3. Hybridomas
6.4.4. Recombinant Cell Lines
Chapter 7. Global Cell Line Development Market, by Application
7.1. Market Snapshot
7.2. Global Cell Line Development Market by Application, Performance – Potential Analysis
7.3. Global Cell Line Development Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
7.4. Cell Line Development Market, Sub Segment Analysis
7.4.1. Bioproduction
7.4.2. Tissue Engineering & Regenerative medicine
7.4.3. Toxicity Testing
7.4.4. Research
7.4.5. Drug Discovery
Chapter 8. Global Cell Line Development Market, Regional Analysis
8.1. Cell Line Development Market, Regional Market Snapshot
8.2. North America Cell Line Development Market
8.2.1. U.S. Cell Line Development Market
8.2.1.1. Product breakdown estimates & forecasts, 2017-2027
8.2.1.2. Type breakdown estimates & forecasts, 2017-2027
8.2.1.3. Application breakdown estimates & forecasts, 2017-2027
8.2.2. Canada Cell Line Development Market
8.3. Europe Cell Line Development Market Snapshot
8.3.1. U.K. Cell Line Development Market
8.3.2. Germany Cell Line Development Market
8.3.3. France Cell Line Development Market
8.3.4. Spain Cell Line Development Market
8.3.5. Italy Cell Line Development Market
8.3.6. Rest of Europe Cell Line Development Market
8.4. Asia-Pacific Cell Line Development Market Snapshot
8.4.1. China Cell Line Development Market
8.4.2. India Cell Line Development Market
8.4.3. Japan Cell Line Development Market
8.4.4. Australia Cell Line Development Market
8.4.5. South Korea Cell Line Development Market
8.4.6. Rest of Asia Pacific Cell Line Development Market
8.5. Latin America Cell Line Development Market Snapshot
8.5.1. Brazil Cell Line Development Market
8.5.2. Mexico Cell Line Development Market
8.6. Rest of The World Cell Line Development Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. American Type Culture Collection (ATCC)
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Lonza Group AG
9.2.3. Thermo Fisher Scientific Inc
9.2.4. GE Healthcare
9.2.5. Sigma-Aldrich Corporation
9.2.6. Selexis SA
9.2.7. European Collection of Cell Cultures (ECACC)
9.2.8. Corning, Inc
9.2.9. WuXi AppTec, Inc
9.2.10. Sartorious AG
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

TABLE 1. Global Cell Line Development market, report scope
TABLE 2. Global Cell Line Development market estimates & forecasts by Region 2017-2027 (USD Billion)
TABLE 3. Global Cell Line Development market estimates & forecasts by Product 2017-2027 (USD Billion)
TABLE 4. Global Cell Line Development market estimates & forecasts by Type 2017-2027 (USD Billion)
TABLE 5. Global Cell Line Development market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 6. Global Cell Line Development market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Cell Line Development market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Cell Line Development market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Cell Line Development market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Cell Line Development market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Cell Line Development market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Cell Line Development market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Cell Line Development market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Cell Line Development market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Cell Line Development market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. U.S. Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. U.S. Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 18. U.S. Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 19. Canada Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Canada Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 21. Canada Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 22. UK Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 23. UK Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. UK Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 25. Germany Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 26. Germany Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. Germany Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 28. RoE Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 29. RoE Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. RoE Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 31. China Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 32. China Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. China Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 34. India Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 35. India Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. India Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 37. Japan Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 38. Japan Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. Japan Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 40. RoAPAC Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 41. RoAPAC Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. RoAPAC Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 43. Brazil Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 44. Brazil Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. Brazil Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 46. Mexico Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 47. Mexico Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. Mexico Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 49. RoLA Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 50. RoLA Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. RoLA Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 52. Row Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 53. Row Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Row Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Cell Line Development market
TABLE 56. List of primary sources, used in the study of global Cell Line Development market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered

FIG 1. Global Cell Line Development market, research methodology
FIG 2. Global Cell Line Development market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Cell Line Development market, key trends 2019
FIG 5. Global Cell Line Development market, growth prospects 2020-2027
FIG 6. Global Cell Line Development market, porters 5 force model
FIG 7. Global Cell Line Development market, pest analysis
FIG 8. Global Cell Line Development market, value chain analysis
FIG 9. Global Cell Line Development market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Cell Line Development market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Cell Line Development market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Cell Line Development market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Cell Line Development market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Cell Line Development market, regional snapshot 2017 & 2027
FIG 15. North America Cell Line Development market 2017 & 2027 (USD Billion)
FIG 16. Europe Cell Line Development market 2017 & 2027 (USD Billion)
FIG 17. Asia pacific Cell Line Development market 2017 & 2027 (USD Billion)
FIG 18. Latin America Cell Line Development market 2017 & 2027 (USD Billion)
FIG 19. Global Cell Line Development market, company market share analysis (2019)















【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の細胞株開発市場2020-2027:製品別(機器、培地、試薬)、種類別、用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆